Stockscreener 앱 받기
3.00
1.01%
0.03
시간 외 거래:
3.03
0.03
+1.00%
전일 마감가:
$2.97
열려 있는:
$3.05
하루 거래량:
8.46M
Relative Volume:
1.61
시가총액:
$676.43M
수익:
-
순이익/손실:
$-283.26M
주가수익비율:
-2.0408
EPS:
-1.47
순현금흐름:
$-273.61M
1주 성능:
-23.27%
1개월 성능:
-22.88%
6개월 성능:
+0.33%
1년 성능:
-35.62%
1일 변동 폭
$2.95
$3.255
1주일 범위
$2.88
$4.365
52주 변동 폭
$1.26
$7.30
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.00 | 958.61M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-03-18 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-11-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Rodman & Renshaw | Buy |
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Sana Biotechnology: A High-Risk, High-Reward Play on a Potential Diabetes Cure - AInvest
Sana Biotechnology options signal 10.8% potential stock price movement after earnings - AInvest
Quant Funds Rotate Into Sana Biotechnology Inc. StockReal-Time Analysis With Entry Targets In Progress - beatles.ru
Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects - MSN
Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued (NASDAQ:SANA) - Seeking Alpha
Sana Biotechnology shares rise 3.03% premarket after pricing $75 million share offering. - AInvest
Seattle biotech firm Sana Biotechnology raising $75 million through public offering - The Business Journals
Sana Biotechnology Announces Public Offering Pricing - TipRanks
Sana Biotechnology Announces $69.9mln Public Offering of 20.9mln Shares - AInvest
ALRM shifts unused 2015 shares to 2025 equity plan; no new dilution | SANA SEC FilingForm 8-K - Stock Titan
Sana Biotechnology (SANA.O) Plummets 28% – What’s Behind the Sudden Drop? - AInvest
Sana Biotechnology Plummets 30.5% Intraday: A Technical and Order-Flow Deep Dive - AInvest
Sana Biotechnology Plummets 30%: A Bearish Storm Unfolds as Capital Raise Sparks Investor Exodus - AInvest
Sana Biotechnology stock tumbles after pricing public offering By Investing.com - Investing.com Canada
Sana Biotechnology stock tumbles after pricing public offering - Investing.com
Why Is Sana Biotechnology Stock Down 25% Today? - TipRanks
SANA Stocks Defy Expectations in Market - timothysykes.com
Sana Biotechnology shares fall 24.71% premarket after announcing a public offering of $75.0 million of shares. - AInvest
Sana Biotechnology slides after $75 mln equity offering - TradingView
Sana Biotechnology Raises $75 Million Through Share Offering - AInvest
Sana Biotechnology Prices $75 Million Share Offering - MarketScreener
Sana Biotechnology shares fall 16% premarket after announcing a public offering of $75.0 million of shares. - AInvest
Sana Biotechnology prices $75 million public offering at $3.35 per share - Investing.com Nigeria
Sana Biotechnology Announces Pricing of Public Offering - The Manila Times
Sana Biotechnology announces pricing of public offering at $3.35 per share - MarketScreener
Sana Biotechnology Announces $75M Public Offering of Common Stock and Pre-Funded Warrants - AInvest
Sana Biotechnology Announces Pricing of Public Offering - Benzinga
Sana Biotechnology after launching $75 mln stock deal - TradingView
Sana Biotechnology launches $75 million public offering - Investing.com
Sana Biotechnology launches $75 million public offering By Investing.com - Investing.com Canada
Sana Biotechnology shares fall 14.12% after-hours following Seres Therapeutics' board changes and clinical advancement updates. - AInvest
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Sana Biotechnology shares rise 1.42% after-hours following positive study results on HIP-modified pancreatic islet cells. - AInvest
Sana Biotechnology Announces Publication in New England - GlobeNewswire
Revolutionary Type 1 Diabetes Breakthrough: Patient Produces Insulin After 35 Years Through Novel Cell Transplant - Stock Titan
Sana Biotechnology Inc expected to post a loss of 21 cents a shareEarnings Preview - TradingView
What analysts say about Sana Biotechnology Inc. stockHigh-yield capital appreciation - Jammu Links News
What catalysts could drive Sana Biotechnology Inc. stock higher in 2025Achieve fast wealth growth with smart picks - Jammu Links News
When is Sana Biotechnology Inc. stock expected to show significant growthGet exclusive market insights for better trading - Jammu Links News
Is it the right time to buy Sana Biotechnology Inc. stockAmplify your gains with low-risk picks - Jammu Links News
What is the dividend policy of Sana Biotechnology Inc. stockUnprecedented profits - Jammu Links News
What are the technical indicators suggesting about Sana Biotechnology Inc.Maximize gains with data-driven trading alerts - Jammu Links News
Sana Biotechnology Inc. Stock Analysis and ForecastAchieve consistent profits with expert advice - Jammu Links News
What is Sana Biotechnology Inc. company’s growth strategyMaximize gains with data-driven trading alerts - Jammu Links News
Citi Remains Bullish on Sana Biotechnology (SANA) - MSN
Drawdown in Sana Biotechnology Inc. May Be Nearing EndHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it
Citi Maintains Buy Rating on Sana Biotechnology with $15 Price Target - AInvest
Is Sana Biotechnology Inc. a growth stock or a value stockFree Stock Recommendation For Fast Growth - jammulinksnews.com
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):